stockrow
Friday 6 November 2026
Export AMN’s income statement to Excel — free account
AMN Healthcare Services Inc
AMN Healthcare Medical Care Facilities
AMN Healthcare Services Inc’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, down 8.49% from fiscal 2024.
- Revenue
- +13.1%
- EPS
- +11.8%
- Free cash flow
- −389.4%
- Total debt
- −18.9%
Quarter to September 2026, against a year earlier
37.15
10.27
−21.66%
Follow AMN
Alert me
| Sep '26 From the 10-Q filed 6 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
12.86 | 11.99 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.40 | 0.37 | 0.21 | 0.22 | |
P/FCF ratio |
4.32 | 2.89 | 1.01 | 2.62 | |
P/Operating CF |
(16.03) | (6.65) | 1.27 | 8.03 | |
P/B ratio |
1.81 | 1.70 | 1.00 | 0.95 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.54 | 0.48 | 0.26 | 0.49 | |
EV/EBITDA |
5.46 | 4.75 | 2.88 | 6.36 | |
EV/Operating CF |
5.24 | 3.49 | 1.21 | 4.97 | |
EV/FCF |
5.82 | 3.76 | 1.27 | 5.77 | |
Quick Ratio |
0.38 | 1.02 | 0.96 | 0.80 | |
Current Ratio |
1.21 | 1.13 | 1.09 | 0.94 | |
Net Debt/EBITDA |
0.00 | 6.25 | 1.19 | 16.17 | |
Debt/Assets |
0.00% | 31.43% | 28.51% | 36.63% | |
Debt/Equity |
0.00 | 1.00 | 1.04 | 1.19 | |
Asset Turnover |
1.59 | 1.50 | 1.37 | 1.21 | |
Operating CF/Net income |
(2.62) | (8.98) | 9.05 | (9.82) | |
Capex/Depreciation |
0.00 | (0.27) | (0.20) | (0.21) | |
Interest Coverage |
6.89 | 3.84 | 17.46 | 0.66 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
20.81% | 21.89% | 15.85% | 20.33% | |
Intangible Assets out of Total Assets |
0.43 | 0.43 | 0.39 | 0.50 | |
Share Based Compensation of Revenue |
1.19% | 1.46% | 0.72% | 0.77% | |
Graham Net Nets |
(0.51) | (0.60) | (1.06) | (1.49) | |
Graham Number |
35.27 | 33.97 | 0.00 | 0.00 | |
Earnings Yield |
7.78% | 8.34% | (4.69%) | (15.80%) | |
Free Cash Flow Yield |
23.15% | 34.59% | 98.76% | 38.24% | |
Revenue per Share |
18.34 | 17.25 | 35.43 | 19.42 | |
Operating CF per Share |
(2.24) | (4.87) | 14.46 | 1.96 | |
Capex per Share |
(0.25) | (0.23) | (0.19) | (0.21) | |
Free Cash Flow per Share |
(2.49) | (5.10) | 14.27 | 1.76 | |
Cash per Share |
6.55 | 9.27 | 14.41 | 0.88 | |
Shareholders Equity per Share |
19.82 | 19.00 | 18.32 | 16.67 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
19.82 | 19.00 | 18.32 | 16.67 | |
Free Cash Flow |
(97.33) | (198.97) | 555.21 | 67.63 | |
Working Capital |
137.95 | 98.77 | 92.33 | (32.24) | |
Capital Expenditures |
(9.81) | (9.04) | (7.25) | (7.95) | |
Net Current Asset Value |
(714.23) | (753.44) | (755.05) | (906.62) | |
EV/EBIT |
9.32 | 8.23 | 18.20 | 0.00 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 | |
Price to Operating Income |
6.92 | 6.32 | 14.50 | 0.00 | |
| Other line items | |||||
Average Receivables |
— | 435.77 | 464.67 | 469.45 | |
Average Payables |
180.53 | 184.42 | 196.68 | 173.14 | |
Average Assets |
2,215.96 | 2,288.10 | 2,499.75 | 2,254.92 | |
Average Common Equity |
709.71 | 674.44 | 713.93 | 674.36 |
Columns are period end dates · fundamentals updated 6 Nov 2026